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The technology of whole image acquisition from histological glass slides (Virtual slides, (VS)) and its associated software
such as image storage, viewers, and virtual microscopy (VM), has matured in the recent years. There is an ongoing
discussion whether to introduce VM into routine diagnostic surgical pathology (tissue-based diagnosis) or not, and if these
are to be introduced how best to do this. The discussion also centres around how to substantially define the mandatory
standards and working conditions related to introducing VM. This article briefly describes some hypotheses alongside our
perspective and that of several of our European colleagues who have experienced VS and VM either in research or routine
praxis. After consideration of the different opinions and published data the following statements can be derived: 1.
Experiences from static and remote telepathology as well as from daily routine diagnoses, confirm that VM is a diagnostic
tool that can be handled with the same diagnostic accuracy as conventional microscopy; at least no statistically significant
differences (p> 0.05) exist. 2. VM possesses several practical advantages in comparison to conventional microscopy; such
as digital image storage and retrieval and contemporary display of multiple images (acquired from different stains, and/or
different cases). 3. VM enables fast and efficient feedback between the pathologist and the laboratory in terms of ordered
additional stains, automated access to the latest research for references, and fast consultation with outstanding
telepathology experts. 4. Industry has already invested “big money” into this technology which certainly will be of
influence in its future development. The main constraints against VM include the questionable reimbursement of the
initial investment, the missing direct and short term financial benefit, and the loss of potential biological identity between
the patient and the examined tissue. This article tries to analyze and evaluate the factors that influence the
implementation of VM into routine tissue-based diagnosis, for example in combination with predictive diagnosis. It
focuses on describing the advantages of modern and innovative electronically based communication technology.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
1245603103708547Introduction
Tissue based diagnosis derived from human tissue(s) still
remains the most reliable method of disease recognition
and classification in both sensitivity and specificity [1]. For
example, in the USA only 272 surgical pathology claims
from 1998–2003 have been reported to have significant
therapeutic consequences and an inter-observer error rate
of 80–95% dependent upon technical procedure (fine nee-
dle aspiration, etc.), and diagnosis (Spitz nevus versusCorrespondence: klaus.kayser@charite.de
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reproduction in any medium, provided the ormelanoma, etc.) [2,3]. All these studies rely on manual
workflow and manual tissue processing. Considerations on
the impact of digitised tissues or slides, and electronic
communication in terms of expert consultation, have not
been included up until now; to our knowledge.
The new technology of image acquisition and digitisa-
tion (virtual slides, (VS)) has been broadly applied in
nearly all Institutes of Pathology related to Universities in
Germany and other European countries. It has been used
for education, storage of rare cases, clinical pathological
conferences, and research assessment such as tissue micro
arrays (TMA) [4,5]. It’s implementation into the routine
research workflow is still in its initial stages. Some privateis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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good results when deriving diagnoses from routinely
acquired VS [6-8].
Which standards and control functions need to be ful-
filled by the corresponding laboratories and technical equip-
ment specialists in order to ascertain or corroborate the
high level of quality of diagnostic surgical pathology in VM?
Conventional laboratory workflow and tissue-based
diagnosis
Human tissue needs to be fixed, processed, cut, stained, and
finally analyzed by a surgical pathologist. Specific equip-
ment is commonly used for fixation, tissue processing, and
staining, which is loaded manually [9,10]. Microtome cuts
usually require manual performance. The whole workflow
is monitored by a laboratory information system (LIS),
which itself is subject to accreditation and certification [11].
Capable LIS report the stages of individual tissues at any
time and step of the workflow [12,13]. The quality of the
obtained slides varies. Slides of good quality allow easier
and more precise diagnoses; although experienced patholo-
gists well versed in specific laboratory parameters can view
slides of poorer quality with similar diagnostic accuracy.
This statement, however, only holds true for “common
H&E based” diagnoses, such as tuberculosis or squamous
cell carcinoma.
The demands of guiding an adequate therapy have led
to the term “tissue–based diagnosis” which includes
H&E based diagnosis, prognosis associated diagnosis
(usually demanding immunohistochemical investigations
(IHC)), predictive diagnosis (usually demanding IHC and
gene mutation analysis (PCR)), and risk estimation,
which is the estimation of risk prior to the establishment
of a certain disease (usually demanding gene analysis
(PCR)) [14,15]. Prognosis associated diagnosis, predictive
diagnosis, and risk estimation are more sensitive to varia-
tions in technical performance in comparison to H&E
based diagnosis. They have to be continuously monitored
and are sensitive to the fixation medium [16]. Derived
from the ring investigations in clinical pathology, IHC
standard stained slides are distributed and judged by refer-
ees in several European countries (Germany, Great Britain,
and others) [17,18]. The diagnostic accuracy is controlled
by distributing VS to surgical pathologists and evaluating
their responses via electronic communication [13,19].
When analyzing the laboratory workflow, a principal
component has to be included: the primary H&E diagnosis
has to be confirmed and further refined by additional la-
boratory procedures such as additional stains like PAS or
Giemsa, etc., IHC or additional investigations such as
PCR, or in situ hybridization, etc. In a laboratory with a
conventional workflow they are ordered by the responsible
pathologist and depend upon the demands of the clinician.
All these actions can be aggregated under the topic reliable“communication” and user – friendly “man – machine
interaction”. Herein, appropriate digital compartments are
essential.
Digital pathology and tissue-based diagnosis
The acquisition of virtual slides and associated virtual mi-
croscopy (VM) to interpret digital images occur close to the
end of the diagnostic chain, typically just before the diagno-
sis is reported. It is useful to distinguish between interactive
and automated VM [20]. Interactive VM is the pathologist’s
diagnostic performance when viewing VS. Automated VM
includes the implementation of computer-aided “diagnostic
assistants” [21]. They can be compared with program assis-
tants that assist in detecting spelling errors in a letter, or in
formatting certain documents, etc. [21,22]. Most vendors
concentrate on interactive VM. Some add IHC measure-
ment programs that have been designed to calculate IHC
scores such as Her2/neu or hormone receptor status in
breast cancer [23]. Outside of gynaecological cytopathology,
automated VM has not been fully implemented to the best
of my knowledge.
Obviously, the quality of VS depends upon the original
slides and upon the colour and spatial accuracy of the
whole slide imaging (WSI) scanner [13,23] which is used.
Most WSI scanners can be equipped with objectives of
different magnification (i.e., x10, x20, and x40) which define
the scanning time and mainly the number of focal z-planes.
In histology (cellular structure based morphology) one indi-
vidual plane is usually sufficient to render a diagnostic inter-
pretation, in contrast to cytology (intra-cellular structure
based morphology) which requires several focal planes (re-
ferring to the Z-axis) [13].
Implementing VM into routine practice offers several
principle advantages, which can be summarized as follows:
1. Once a scanner delivers VS of sufficient diagnostic
quality, the technology generally continues to
produce images of similar quality. Working with a
conventional microscope requires frequent
“resetting” of the focus plane, adjustment of
brightness, etc. Conventional microscope settings
also depend upon personal preferences, which can
be simulated by VS viewers if desired.
2. Several images obtained from different stains of the
same case or tumor can be viewed simultaneously
with VM. This feature allows for a more precise
judgement of prognosis associated diagnosis and
predictive diagnosis.
3. Quantitative evaluation of object and structure features
can be evaluated either interactively or automatically,
which is of assistance in prognosis associated diagnosis
and predictive diagnosis.
4. Annotations can be included for teaching, marking
areas of interest, or discussion purposes in VM.
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ance of tissue-based diagnosis, which are identical with the
constraints of the implementation of VM include:
1. The lack of financial advantage of VM
implementation in conjunction with the decreasing
prices for hardware and software. This is in direct
contrast to the financial advantage of implementing
digital imaging on live images in disciplines such as
radiology, which saves the expenses of paper based
diagnosis (films). The investigations are not
negligible and can amount to about 20% of the gross
budget dependent upon the size of the pathology
institute (private estimation). There seem to be no
savings when implementing VM, because the
processes in the laboratory mainly remain untouched
and only the workflow is affected. Some authors
however have mentioned the comparable save in
labour when retrieving a case and the increased
safety of diagnoses using VM [6,8]. However, these
are only secondary savings, and mainly depend upon
the local environment [4,24].
2. Security of the patient’s diagnosis, and the possibility
to control the origin of the glass slides by finger
printing the patient’s DNA at any time. Obviously,
this cannot be stated in VS, however, modern
electronic safety controls permit an unambiguous
relationship between the VM and the original glass
slides [25].
3. Additional arguments such as difficulties to view and
diagnose VS compared to conventional microscopes
depend more or less on training and performance of
the individual pathologist [24,26,27]. This has also been
demonstrated in teaching courses using VS and
conventional microscopes for medical students in
anatomy [24,28-31]. If appropriately trained, most of
the students in these courses preferred VS compared to
receiving training with conventional microscopes [12].
In summary, VM offers greater advantages than con-
ventional light microscopy with respect to prognosis
associated diagnosis and predictive diagnosis, i.e., for
those types of diagnoses which are closely associated
with guiding patient therapy.
Consecutives
Tissue-based diagnosis still remains related to the
pathologist’s knowledge in both conventional microscopy
and VM. The diagnosis information sources include the
patient’s history, microscopic and gross images, and add-
itional findings (live imaging, etc.). Microscopic images
including VS contribute significantly, however not in
total, to the patient’s diagnosis. The more distinct a diag-
nosis, the more information in addition to microscopicimages is required for an adequate diagnosis to be made
[13,32-34].
The optical pathways are important to obtain good
images, but are not the only prerequisite. Preservation,
fixation, and embedding of tissue, cutting of tissue
blocks, and staining of glass slides also contribute to
VS quality to a high degree. From our experience in
Europe, the WSI scanner performance (i.e. the acquisi-
tion of VS) is of the highest quality to permit diagnos-
tic interpretations to be made.
What can we conclude?
1. The histological diagnosis is based not only on the
final digital image, but also upon a chain of laboratory
procedures with additive external clinical information.
2. Diagnoses have to be delivered at different levels in
relation to the clinical demands and potential
treatment needs of the patient.
3. “Crude diagnoses”, for example H&E diagnoses, are
adequate in many situations, for example in
odontogenic cysts, acute appendicitis, common
nevi, etc.
4. Adequate quality control of histological diagnoses
should start with the final outcome, i.e., analysing
the diagnostic quality of the material being viewed in
relation to the demands of potential therapy.
5. The weakest link in the diagnostic chain should be
addressed with high priority. It can vary - for
example, tissue preservation and fixation are subject
to a broad variance.
6. The optical pathway is the end link in the diagnostic
workflow process, and therefore, of less significance
to associated laboratory reprocessing such as IHC,
ISH, etc.
7. Monitoring intra-laboratory procedures (e.g.,
efficiency and reproducibility of reprocessing and
staining, etc.) should be separated from the
evaluation of diagnosis quality.
8. Evaluation of diagnostic errors should take into
account the therapeutic consequences and the local
environment.
9. Automation of a diagnostic chain process is aimed at
providing a consistent quality of material for making
diagnoses. Its variation should be analyzed with
regard to its influence on the final diagnosis.
10.The most efficient quality assurance in automated
technology is the accuracy afforded by quantification
of measurement.
11.Only VM permits a continuous on-line evaluation of
image quality prior to the pathologist’s diagnostic
statement [1,20].
The emerging tendency to separate pre-diagnostic
workflow steps in the histopathology laboratory from
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make diagnoses are likely to create new quality assur-
ance procedures in agreement with the above listed
statements. The contribution of VS to logistic and
diagnostic inaccuracies is probably less important when
compared with tissue preservation and processing, as
all molecular biology and genetic investigations depend
upon tissue preservation and processing.
Is Europe ready to implement VS in routine diagnostic
surgical pathology?
Many European pathologists can be conservative when
working in a strictly regulated financial environment.
Financial issues play the main role in all non-research
technological or medical investments, and are strictly
separated from research and scientific approaches.
In Germany, to my knowledge, several University
Institutes of Pathology have already undertaken new
efforts to implement VM into routine diagnosis. Finan-
cial issues, in particular the high investment and con-
siderable expense of integrating VM into the existing
LIS, are hard to overcome due to restrictive administra-
tive business plans of routine medical services. Most of
these institutions are already equipped with VS scanners
but none of them are used in routine diagnosis.
Discussions on VS image quality, or accuracy of VM
based diagnosis, play only a minor role if any at all. All ser-
ious reports of telepathology and VS experiences display
congruent evidence that VM is at least an equal if not su-
perior diagnostic tool compared to conventional micros-
copy [1,6,8]. Diagnoses can be evaluated from VS without
legal problems to my knowledge.
Experiences of VM applied in routine diagnosis have been
reported from one private Institute of Pathology located in
Heerlen, The Netherlands [8]. It started with VS based rou-
tine diagnosis in 2006; and then an additional University In-
stitute located in Uppsala, Sweden followed. They reported
no difficulties in performance or increased diagnostic
failures.
Some additional (minor) constraints that might influ-
ence the implementation of VM into routine tissue-
based diagnosis include:
1. The new laboratory and LIS configuration have to be
approved by a new third party certification, which is
again a question of investment.
2. Glass slides have to be stored in VM as usual, in
Germany this is for mandatory for at least 10 years.
Herein, VM produces additional costs, and does not
save money.
3. VM implementation only adds a link to the chain of
laboratory workflow. It can only be used for detailed
workflow monitoring at its end stage, i.e. does not
lower the costs of laboratory certification.4. VM is an appropriate tool to fasten and improve
communication between the laboratory and
pathologist. This is only of importance in large
institutions.
5. VM opens the door to communicative medicine.
Specific medical information obtained from different
sources can be included into VM without substantial
extra effort. Again, large institutions will receive the
highest benefit of this.
6. VS scanners are only a tool and are open to human
error, in the same sense that a car is. The car does
not require specific administrative regulations; wrong
driving is the fault of the driver and not of the car.
7. The scanned VS could be subject to FDA approval
or other inspections, although they are viewed
continuously by pathologists. The scanner itself is of
no harm, and any dysfunction will be immediately
noticed, especially in routine diagnostics.
In conclusion, the recognition of the advantages of
VM by the appropriate administration requires some
intelligence. The idea of the implementation of VM is
an unusual consideration, however, if performed, an ac-
tion which in German would be called “nachhaltig” (its
English equivalent roughly translates to “especially good
in future taking into account less momentary success”;
or to be less precise, “to achieve sustained success”).
Most administrations currently seem to be unable to
perform or permit a “nachhaltige” action, neither in
Germany nor elsewhere in Europe.
However, there remains another option which gives us
hope. This is the enormous amount of money that is
currently invested by the industry, which hints at future
reimbursement by appropriate administrative actions.
Fortunately, no proven scientific or other no financial
constraints against this action seem to exist as far as I
know.Competing interest
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